Back to results
US 12,215,098 B2Granted
Solid form, crystalline form, and crystal form a of FXR agonist, and preparation method and application thereof
AssigneeCspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
InventorsXiaolin Li, Peng Li, Haiying He
Life of this patent
Estimating the term…
Abstract
Disclosed are a solid form, a crystalline form, and crystal form A of a compound of formula (I) used as an FXR agonist, and a preparation method therefor. Also comprised is an application of the compound of formula (I) in preparation of a medication for treating nonalcoholic steatohepatitis (NASH).
Claims17
A crystalline form of a compound of formula (I), which is crystal form A, characterized by X-ray powder diffraction pattern with characteristic diffraction peaks at the following 2θ angles of 12.72±0.2°, and 25.27±0.2°;
Dependencies are inferred from the claim text.